Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon May 10, 2024 9:01am
82 Views
Post# 36033164

RE:RE:RE:70,000 new patients since the start of April.germany

RE:RE:RE:70,000 new patients since the start of April.germany
okgonow wrote:
QContinuum1 wrote:


And LABS had better offer up proper guidance on the call next week if they want to be taken seriously.

If you have a gorilla partner like Stada as an entry point into a fast growing market like that, you had better be ready to explain how well you are or are not doing.

Keith had better have some forward looking guidance ready for Germany, because the call will become a joke very quickly if the best they have is that the 'German market is growing and we hope to expect to maybe see some growth through our channels there'.


yes Q..... i am firmly in your camp on the forward guidance camp the time for wishy washy CC's i over its time to show sharholders and the general market what sets MPL apart from all the rest of of the wannabe pot companys that at this point really cant take advantage of the US news and may only get a small oiece of the German medical legalization pie as it is still far from leagalizing rec-pot.

MPL has a leg up on many also only having $3mill worth of debt (having all their taxes paid) and $18 mill in the bank and suposidly cashflow positive as of April 1 

with having all the GMP cert for multiple markets and the FDA/DEA on top of that they have to show ho they are monetizing all of these cert's and supposedly top of the heap when it comes to Pharmasutical MJ and the products they can supply worldwide ! especially as you said with a monster partner like STRADA in Germany/Europe.


Nervermind the Brazil thing :

"In addition to existing Brazilian customers, the Company entered into a supply agreement with a top-tier generic pharmaceutical company in Brazil in July 2023. Since signing the agreement, the customer has applied to ANVISA for a number of MediPharm produced cannabis product marketing authorizations. The receipt of GMP certification is a key milestone and critical required element of the rigorous ANVISA Pharma product approval process."

you would think there should be something they can report that shows us how big of the piece of pie MPL will have and how much they have sold into that market.

As i have mentioned before a proper PR campaign is needed to show other investors in this segment of the market what sets MPL apart from the others, whats the use of positive stuff happening when no one knows about you. 
especially after so many have lost a ton of money when the first POT craze happened and how this time its different especially MPL and the way they are aproching things this time around.

i have no problem with them doing a share buyback at this point ...especially if we are cash flow positive and the SP is under $.25 
it be nice if management would buy on the open market as well, nothing says I BELIVE in the companys future like Insider buying!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!




PS;

The Time is now as many of us may be t the point of realocating funds into other sectors that are on fire epecially the Gold/Energy stocks!

Risk and Reward ....If MPL cant show that the risk is beeing mitigated and the reward isnt going to happen (especialy us sitting at $.08 ) at the very least a tripple in the near future whats the use of investors leaving their money invested with them?!
<< Previous
Bullboard Posts
Next >>